Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001144204-16-106844

Options or other derivatives

  • President and CEO acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

GILL JOHN · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-06-01 Grant or award : show line 1 in the form Stock option (right to buy) +100,000 $2.20 $220,000 100,000 D
Loading xslF345X03/v441657_4.xml…